{{expand|time=2009-07-31T05:09:44+00:00}}
{{medical}}
{{drugbox
| IUPAC_name = 4-amino-1-[3,3-difluoro-4-hydroxy-5- (hydroxymethyl) tetrahydrofuran-2-yl]- 1H-pyrimidin- 2-one
| image = Gemcitabine.svg
| width=200
| image2 = Gemcitabine-hydrochloride-from-xtal-3D-balls.png
| IUPHAR_ligand = 4793
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 95058-81-4
| ATC_prefix = L01
| ATC_suffix = BC05
| ATC_supplemental =  
| PubChem = 60750
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00441
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 54753
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = B76N6SBZ8R
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02368
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 175901
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 888
| C=9 | H=11 | F=2 | N=3 | O=4
| molecular_weight = 263.198 g/mol
| bioavailability = 
| protein_bound = <10%
| metabolism = 
| elimination_half-life = Short infusions 32-94 minutes<br/>for long infusions 245-638 minutes
| routes_of_administration = 口服，静脉注射
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X --> D
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| legal_status = 
}}
'''吉西他滨'''（{{lang-en|Gemcitabine}}），是用于[[化学疗法|化学疗法]]的[[核苷|核苷]]类似物。[[礼来公司|礼来公司]]的注册商品名为'''健择'''（Gemzar）。<ref>[http://www.cmt.com.cn/article/080814/a080814b0601.htm 2008 ASCO年会吉西他滨(健择)最新研究进展荟萃(上)]</ref>

== 药理学 ==
结构是[[去氧胞苷|去氧胞苷]]2'[[碳|碳]]上的[[氢|氢]]原子换成了[[氟|氟]]原子。与[[5-氟尿嘧啶|5-氟尿嘧啶]]和其它[[嘧啶类似物|嘧啶类似物]]一样，药物在[[DNA复制|DNA复制]]时改变了[[核酸|核酸]]的一个组分，吉西他滨改变的是[[胞苷|胞苷]]。

== 适应症 ==
临床上主要用于治疗非小细胞肺癌、胰腺癌、膀胱癌、乳腺癌和其他实体肿瘤。

== 参考 ==
{{Reflist}}

== 外部链接 ==
* [http://www.gemzar.com/ Gemzar.com]

{{化疗药物}}

[[Category:礼来公司|Category:礼来公司]]
[[Category:抗肿瘤抗代谢物|Category:抗肿瘤抗代谢物]]
[[Category:有机氟化合物|Category:有机氟化合物]]
[[Category:嘧啶酮|Category:嘧啶酮]]